Hypervascular Tumors clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Obsidio™ Conformable Embolic Registry

    Sorry, not currently recruiting here

    OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects …

    Los Angeles, California and other locations

Our lead scientists for Hypervascular Tumors research studies include .

Last updated: